A multicentre randomized controlled trial of the efficacy and safety of single-dose praziquantel at 40 mg/kg vs. 60 mg/kg for treating intestinal schistosomiasis in the Philippines, Mauritania, Tanzania and Brazil.

Piero Olliaro,Michel Vaillant,Vincente J. Belizario,Nicholas J.S. Lwambo,Mohamed Ouldabdallahi,Otávio Sarmento Pieri,Maria Lourdes E. Amarillo,Godfrey M. Kaatano,Mamadou Diaw,AnaLucia C. Domingues,Tereza Cristina Favre,Olivier Lapujade,Fabiana Alves,Lester Chitsulo

A multicentre randomized controlled trial of the efficacy and safety of single-dose praziquantel at 40 mg/kg vs. 60 mg/kg for treating intestinal schistosomiasis in the Philippines, Mauritania, Tanzania and Brazil.

2011

Piero Olliaro
Michel Vaillant
Vincente J. Belizario
Nicholas J.S. Lwambo
Mohamed Ouldabdallahi
Otávio Sarmento Pieri
Maria Lourdes E. Amarillo
Godfrey M. Kaatano
Mamadou Diaw
AnaLucia C. Domingues
Tereza Cristina Favre
Olivier Lapujade
Fabiana Alves
Lester Chitsulo

Background Praziquantel at 40 mg/kg in a single dose is the WHO recommended treatment for all forms of schistosomiasis, but 60 mg/kg is also deployed nationally.

Keywords:

Randomized controlled trial
Tanzania
Immunology
Intention-to-treat analysis
Praziquantel
Schistosomiasis
Intestinal schistosomiasis
Adverse effect
Medicine
treatment outcome

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations